SR-18292 Maleate has been used as a peroxisome proliferator-activated receptor ? coactivator 1 ? (PGC1?) inhibitor to study the protective effects of pioglitazone on demyelinated axons.
Biochem/physiol Actions
SR-18292 is a potent and specific inhibitor of hepatic gluconeogenesis via increased acetylation of PGC-1α and suppression of gluconeogenic gene expression. SR-18292 reduces blood glucose and increases hepatic insulin sensitivity in mouse models of T2D.